ArticleBrain and behavior2025
Preventing Neurons and Glial Cells Destruction in Substantia Nigra Pars Compacta and Striatum Using St. John's Wort and Stem Cells on Parkinson's Model.
Article in Brain and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mesenchymal Stem Cell-Based Therapies Applied in Neurological Diseases: A Systematic Review.Biomedicines · 2026Review
- Preventing Neurons and Glial Cells Destruction in Substantia Nigra Pars Compacta and Striatum Using St. John's Wort and Stem Cells on Parkinson's Model.Brain and behavior · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
STUDY
objectiveSt. John's wort (Hypericum perforatum) has been used for centuries as a medicinal plant to remedy external disorders such as burns and wounds, as well as internal disorders such as nerve pain, anxiety, and depression. Bone marrow mesenchymal stem cells (BMSCs) are a heterogeneous population of pluripotent stromal cells that can differentiate into a variety of cell types. The aim of the study was to individually and combinationally investigate the effect of whole extract and stem cells on Parkinson's disease. Furthermore, using a new method for stem cells transplantation to enhance cell integration into substantia nigra pars compacta (SNC) and striatum.
methodsIn the study, 63 adult male Wistar rats were classified, and among them, treatment groups received 20 mg/kg extract (intraperitoneally; 28 days) and nearly 1 million (mean of 936 × 10
resultsHistological evaluations revealed that there has been a sharp rise in neurons in both ventral and dorsal striatum in the pretreatment plus cell group (p < 0.001). Regarding neurons in SNC area, quantitative investigations via Nissl and immunohistochemistry staining showed significant differences between the lesion group and groups receiving pretreatment, treatment plus cells, and pretreatment plus cells (p < 0.001). According to evidence, there are some communications between St. John's wort and stem cells that have led to navigate stem cells to immigrate and deploy within striatum.
conclusionThe study found that both H. perforatum extract and BMSCs can help preserve dopaminergic neurons and glial cells during which combination therapy demonstrates synergy as an indicator. St. John's is a natural preserver and appears to function as a neuroprotective agent and facilitate the navigation and integration of stem cells; consequently, it keeps surviving both neurons and glial cells against pathogens and destructive environmental factors and has a potential to help us and Parkinson's patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.